Lataa...
Soluble Urokinase‐Type Plasminogen Activator Receptor, Changes of 24‐Hour Blood Pressure, and Progression of Chronic Kidney Disease
BACKGROUND: Soluble urokinase‐type plasminogen activator receptor (suPAR) is associated with cardiovascular risks and poor renal outcomes. However, whether elevated suPAR levels are associated with 24‐hour blood pressure patterns or kidney disease progression in patients with chronic kidney disease...
Tallennettuna:
| Julkaisussa: | J Am Heart Assoc |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955457/ https://ncbi.nlm.nih.gov/pubmed/33325248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017225 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|